Fibrotic Events in the Progression of Cholestatic Liver Disease
Cholestatic liver diseases including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are associated with active hepatic fibrogenesis, which can ultimately lead to the development of cirrhosis. However, the exact relationship between the development of liver fibrosis and th...
Main Authors: | Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matías A. Ávila, Yulia A. Nevzorova, Francisco Javier Cubero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1107 |
Similar Items
-
4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt Signaling Pathways
by: Yi-Jen Liao, et al.
Published: (2020-08-01) -
Prominin‐1‐expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury
by: Michael Fenlon, et al.
Published: (2020-07-01) -
Curcumin- and Cyclopamine-Loaded Liposomes to Enhance Therapeutic Efficacy Against Hepatic Fibrosis
by: Zhang T, et al.
Published: (2020-12-01) -
The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
by: Takahiro Nishio, et al.
Published: (2022-10-01) -
Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice
by: Qianyuan Gong, et al.
Published: (2022-10-01)